ω-3 Polyunsaturated fatty acids prevent pressure overload-induced ventricular dilation and decrease in mitochondrial...

Area of Science:

• Cardiovascular Biology
• Mitochondrial Medicine
• Nutritional Science

Background:

• Pathological left ventricular (LV) hypertrophy can lead to heart failure with reduced mitochondrial function.
• Marine ω-3 polyunsaturated fatty acids (ω-3 PUFA) are known to influence adiponectin and prevent LV dilation in certain models.
• Understanding the mechanisms behind ω-3 PUFA's cardioprotective effects is crucial for managing heart conditions.

Purpose of the Study:

• To investigate the impact of ω-3 PUFA on LV dilation and mitochondrial enzyme activity after pressure overload.
• To determine if adiponectin mediates the beneficial effects of ω-3 PUFA on the heart.

Main Methods:

• Wild type and adiponectin knockout mice underwent transverse aortic constriction (TAC) and received standard chow with or without ω-3 PUFA.
• Echocardiography assessed LV function, and mitochondrial enzyme activities were measured post-TAC.
• The study compared responses between different mouse strains and dietary interventions.

Main Results:

• TAC induced significant LV hypertrophy and dysfunction in wild-type mice, which was mitigated by ω-3 PUFA treatment.
• ω-3 PUFA attenuated the reduction in mitochondrial enzyme activity and prevented LV dilation in wild-type mice.
• Adiponectin knockout mice showed no adverse cardiac remodeling or mitochondrial dysfunction after TAC and did not benefit from ω-3 PUFA.

Conclusions:

• ω-3 PUFA administration effectively attenuates cardiac pathology resulting from pressure overload.
• The cardioprotective effects of ω-3 PUFA in this model are independent of adiponectin.
• These findings highlight a novel therapeutic pathway for pressure-induced heart disease.